HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Sibu Launches New Topical Products While Raising Sea-Buckthorn Awareness

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Sibu Beauty is launching three new topical products - with plans for further line extensions - while working to raise awareness of its brand and core ingredient, the "superfood" sea buckthorn

You may also be interested in...



Cosmoprof Show in Brief

Firms highlighted ingredients from far-flung locales at Cosmoprof North America July 22-24. While AHAVA marketed Deadsea minerals in its new Comforting Cream and The Leakey Collection promoted marula oil sourced from rural Kenya, Amika Hair Care extended its Obliphica line with products harnessing the benefits of sea buckthorn, a berry that thrives in extremely harsh conditions in Siberia.

New Products In Brief

Sibu Beauty Adds To Sea-Buckthorn Line

New Products In Brief

Sibu Beauty Adds To Sea-Buckthorn Line

Table

View full table

Related Content

HBW Insight
HBW Insight
Tags:
Latest Headlines

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

See All
UsernamePublicRestriction

Register

RS016841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By